SAJDVD: VOLUME 10, ISSUE 4, NOVEMBER 2013
This journal is now available to be viewed via our eJournal publication viewer.
  1. From policy implementation issues to diabetes in the digital age : editorial
    Authors: Mahomed, F.A.; Published: 2013
    From: South African Journal of Diabetes and Vascular Disease, Vol 10, Issue 4, Nov, Pages: 119
    Full text: Click here to order »
    Full text: Click here to read online »
    Full text: Click here to read via Sabinet » (Login Required)
    Abstract: This issue of the Journal has several important themes, including excellence in diabetes - missed opportunities for optimal care, the digital age and diabetes, diabetes and audiology, a review of diabetic macular oedema, a discussion on non-nutritive sweeteners, the CDE Watch, notes on the Novo Nordisk Update Symposium, and more.
     
  2. What is the ideal drug for the treatment of diabetic macular oedema? : review
    Authors: Kruse, Carl-Heinz; Published: 2013
    From: South African Journal of Diabetes and Vascular Disease, Vol 10, Issue 4, Nov, Pages: 120-121, 133
    Full text: Click here to order »
    Full text: Click here to read online »
    Full text: Click here to read via Sabinet » (Login Required)
    Abstract: Diabetes causes multiple end-organ damage, primarily due to microvascular disease. In the eye, retinal damage (diabetic retinopathy) can broadly be divided into (1) proliferative diabetic retinopathy (PDR) with characteristic vascular proliferation, gliosis and eventual retinal detachment, and (2) diabetic macular oedema (DMO), which leads to eventual destruction of photoreceptors in the central vision. DMO is the leading cause of permanent blindness in diabetics.
     
  3. 'Digital diabetes' - looking to the future : review
    Authors: Wake, Deborah J.; Cunningham, Scott G.; Published: 2013
    From: South African Journal of Diabetes and Vascular Disease, Vol 10, Issue 4, Nov, Pages: 122-126
    Full text: Click here to order »
    Full text: Click here to read online »
    Full text: Click here to read via Sabinet » (Login Required)
    Abstract: In the UK, 85% of adults use the internet, yet digital technology and web-based applications have been slow to realise their potential within healthcare. Diabetes, a chronic disease requiring extensive self-management, could particularly benefit from an e-health approach. While there are a number of independent on-line diabetes communities, mobile apps, websites and networking opportunities, these operate in silos rather than integrating with mainstream healthcare. This review will explore the political drivers and barriers to e-health, and review current digital opportunities for patients and healthcare professionals within diabetes care.
     
  4. Diabetes and the audiologist : is there need for concern regarding hearing function in diabetic adults? : research article
    Authors: Khoza-Shangase, K.; Pillay, D.; Moolla, A.; Published: 2013
    From: South African Journal of Diabetes and Vascular Disease, Vol 10, Issue 4, Nov, Pages: 127-133
    Full text: Click here to order »
    Full text: Click here to read online »
    Full text: Click here to read via Sabinet » (Login Required)
    Abstract: Background: The main aim of the current pilot study was to describe the auditory function of individuals diagnosed with type 1 diabetes mellitus (T1DM) in Johannesburg, Gauteng.
    Methods: A quasi-experimental, non-equivalent control-group design was used. A non-probability purposive sample of nine adults with T1DM and nine healthy adults with normal hearing were recruited and assessed at the University's Speech and Hearing Clinic (USHC). Data collection involved detailed case history taking, otoscopic examination, tympanometry, pure-tone audiometry, speech audiometry and diagnostic distortion product otoacoustic emissions (DPOAE) testing. Findings were analysed descriptively and through inferential statistics (Fisher's exact test and the independent samples t-test).
    Results: Individuals with T1DM presented with normal middle ear function and no middle ear pathology, as suggested by the otoscopic examination and impedance audiometry. Hearing levels were within normal limits even though thresholds were elevated at 6 000 Hz. Speech audiometry results were found to be elevated in this group, with reduced DPOAE amplitudes in the high frequencies.
    Conclusion: Current findings imply that microvascular complications of T1DM may cause damage to the outer hair cells, resulting in reduced DPOAE amplitudes and elevated thresholds in the high frequencies as well as in speech reception and discrimination levels. These findings highlight the need for future studies on a larger sample size for generalisability, with inclusion of older participants with T1DM.
     
  5. Excellence in diabetes : missed opportunities for optimal care : diabetes educators' focus
    Authors: Naidoo, N.; Published: 2013
    From: South African Journal of Diabetes and Vascular Disease, Vol 10, Issue 4, Nov, Pages: 134-138
    Full text: Click here to order »
    Full text: Click here to read online »
    Full text: Click here to read via Sabinet » (Login Required)
    Abstract:The exponential increase in incidence of diabetes and other non-communicable diseases, such as cardiovascular diseases, hypertension, stroke, hyperlipidaemias and certain cancers are associated to a large extent with a growing epidemic of obesity, and lifestyle issues, mainly as a result of lack of exercise, dietary indiscretion, smoking and excessive alcohol consumption.
     
  6. Non-nutritive sweeteners : good or bad? : keep and copy series
    Authors: Amod, Ruwaida; Published: 2013
    From: South African Journal of Diabetes and Vascular Disease, Vol 10, Issue 4, Nov, Pages: 139-141
    Full text: Click here to order »
    Full text: Click here to read online »
    Full text: Click here to read via Sabinet » (Login Required)
    Abstract: There is much debate surrounding the use of non-nutritive sweeteners (NNS) among consumers and more so in the diabetic population. Previous uses of artificial sweeteners included to improve glycaemic control, achieve energy balance and assist in weight reduction. Current research is examining whether the benefits of utilising NNS to achieve these goals outweigh the risks, primarily on a long-term basis.
     
  7. Love and passion make all the difference when managing patients with diabetes : diabetes personality
    Authors: Wagenaar, P.; Published: 2013
    From: South African Journal of Diabetes and Vascular Disease, Vol 10, Issue 4, Nov, Pages: 143-144
    Full text: Click here to order »
    Full text: Click here to read online »
    Full text: Click here to read via Sabinet » (Login Required)
    Abstract: Dr Ashley Murugan is this year's winner of the Servier award for Community Involvement in Diabetes, presented each year at the Centre for Diabetes and Endocrinology's (CDE's) annual Postgraduate Forum in Diabetes Management. He describes himself as 'shocked' to have received the award, having opened his diabetes clinic only in 2011.
     
  8. Novo Nordisk Changing Diabetes® cycle relay : diabetes news
    Authors: Published: 2013
    From: South African Journal of Diabetes and Vascular Disease, Vol 10, Issue 4, Nov, Pages: 145
    Full text: Click here to order »
    Full text: Click here to read online »
    Full text: Click here to read via Sabinet » (Login Required)
    Abstract: Blowing winds and pouring rain were no match for the 16 cyclists who departed from Johannesburg on Thursday morning 7 November with the intension of cycling 1 200 km to George in a bid to raise funds and awareness for diabetes. The 2013 Changing Diabetes cycle relay started at Novo Nordisk offices in Rivonia, Johannesburg, and the teams arrived in George 48 hours later.
     
  9. The journey towards glycaemic control : is it influenced by drug of choice or inertia?
    Novo Nordisk - Accu-Chek® Diabetes Update Symposium : report
    Authors: Hardy, G.; Published: 2013
    From: South African Journal of Diabetes and Vascular Disease, Vol 10, Issue 4, Nov, Pages: 146-148
    Full text: Click here to order »
    Full text: Click here to read online »
    Full text: Click here to read via Sabinet » (Login Required)
    Abstract: Novo Nordisk and Roche Diagnostics co-hosted the Diabetes Update Symposium, a satellite session affiliated to the August 2013 Centres for Diabetes and Endocrinology (CDE) meeting held in Boksburg. Novo Nordisk celebrated a milestone 90th birthday in 2013. In opening remarks, Dr Timmy Kedijang (general manager, Novo Nordisk SA) reaffirmed that as one of the first companies to produce insulin, Novo Nordisk remains committed to innovation in diabetes care in a socially, environmentally and financially sustainable manner.
     
  10. CDE watch : 2013 update from the Centres for Diabetes : summaries
    Authors: Wagenaar, P.; Published: 2013
    From: South African Journal of Diabetes and Vascular Disease, Vol 10, Issue 4, Nov, Pages: 149-152
    Full text: Click here to order »
    Full text: Click here to read online »
    Full text: Click here to read via Sabinet » (Login Required)
    Abstract: Insulin: friend or foe?
    Novel and emerging basal insulin preparations
    Diabetic nephropathy: countdown to disaster? The Ascending Star lecture
    Neuropathy: a diagnosis?
    The debate renewed... Is bariatric surgery a 'cure' for diabetes?
RELIABLE EXPERT INFORMATION
The SAJDVD’s main focus is providing new and relevant information for doctors, nurses and allied professionals involved in caring for the diabetes patient.

But as we are part of the larger Diabetes team, we would like to reach out to all patients with relevant information. So here it is!
All Rights Reserved 2016 © Clinics Cardive Publishing (Pty) Ltd.
The content on this website is intended for healthcare professionals unless stated otherwise.

Advertisements on this website do not constitute a guarantee or endorsement by the journal or publisher of the quality or value
of such products or of the claims made for it by its manufacturer.

Website Development by Design Connection.